Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Saila:Vestnik Transplantologii i Iskusstvennyh Organov
Gaiak:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Sarrera elektronikoa:https://journal.transpl.ru/vtio/article/view/1194
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak